FIELD: medicine, pharmacology, pharmacy.
SUBSTANCE: invention relates to the injection solution based on nalbuphine hydrochloride eliciting the expressed analgesic effect, and to a method for its preparing. The injection solution comprises the following components, wt.-%: nalbuphine hydrochloride, 0.8-2.2; buffer mixture, 0.5-3.5; stabilizing agent, 0.15-0.25; Trilon B (chelating component), 0.001-0.2, and water, the balance. Invention provides preparing the domestic preparation with analgesic effect and stability for above 2.5 years.
EFFECT: improved and valuable medicinal properties of solution.
11 cl, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BUTORPHANOL-BASE INJECTION SOLUTION POSSESSING ANALGESIC EFFECT | 2006 |
|
RU2312662C1 |
| SOLUTION FOR INJECTIONS CONTAINING NALBUPHINE | 2012 |
|
RU2483731C1 |
| MEANS FOR EFFECTIVE CUPPING OF ACUTE AND/OR CHRONIC PAIN SYNDROME AND METHOD OF ITS APPLICATION | 2016 |
|
RU2622980C1 |
| INJECTION DOSAGE FORM FOR TREATING ACUTE ISCHEMIC STROKE AND CRANIOCEREBERAL INJURY, METHOD FOR PREPARING AND USING | 2009 |
|
RU2431496C2 |
| PHARMACEUTICAL COMPOSITION WITH ANALGESIC ACTIVITY IN INJECTION FORM (VERSIONS) | 2013 |
|
RU2563211C2 |
| SOLUTION FOR INTRAVENOUS AND INTRAMUSCULAR INTRODUCTION BASED ON BROMO-DIHYDROCHLOR-PHENYL-BENZODIAZEPINE AND METHOD OF PREPARATION THEREOF | 2015 |
|
RU2605824C1 |
| LIQUID PREPARATION CONTAINING CAMPTOTHECIN DERIVATIVE AND PHARMACEUTICAL COMPOSITION PREPARED BY LYOPHILIZATION OF PREPARATION | 2003 |
|
RU2315623C2 |
| AGENT FOR REDUCTION OF GLUTAMATE-INDUCED APOPTOSIS AND INHIBITION OF NMDA-RECEPTOR, POSSESSING IMMUNOMODULATORY ACTION, FOR TREATING NERVOUS SYSTEM DISORDERS, EFFECTS OF CRANIOCEREBERAL INJURY AND ISCHEMIC AND HEMORRHAGIC STROKE | 2013 |
|
RU2605339C2 |
| EYE DROPS FOR TREATING AGE-RELATED NUCLEAR CATARACT | 2019 |
|
RU2720676C2 |
| STABLE AQUEOUS SOLUTION | 2014 |
|
RU2665639C2 |
